Id	Study	Session	StudySession	SL	TL	Task	Text	Part	SGroup	TGroup	STid	SGid	STseg	TokS	LenS	TTid	TGid	TTseg	TokT	LenT	Ins	Del	Munit	InEff	FixS	TrtS	OrtS	OrtT	MU1rtS	MU1rtT	FFTimeS	FFDurS	FixT	TrtT	FFTimeT	FFDurT	CrossS	CrossT	Pause	Dur	End	Edit	Pause1	Time1	Ins1	Del1	Dur1	End1	Edit1	Pause2	Time2	Ins2	Del2	Dur2	End2	Edit2	PauseR	TimeR	InsR	DelR	DurR	EditR	Edit
1	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	How	Wie	1	1	1	1	3	1	1	1	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
2	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	does_work	funktioniert	2	2+4	1	2	8	2	2	1	1	9	26	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	86019	83164	169183	funktioniert_	86019	86019	13	0	2496	88515	funktioniert_[	0	0	0	0	0	0	---	0	0	0	0	0	---	funktioniert_
3	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	3	3	1	1	8	3	3	1	1	8	0	24	1	-1.0870	0	0	0	0	0	0	0	0	0	0	0	0	1	-1	16926	71854	265842	[netiebra_uz_	16926	193988	0	12	1294	195282	netiebra_uz_	0	0	0	0	0	0	---	0	0	0	0	0	---	[netiebra_uz_
4	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	?	?	5	5	1	1	1	4	4	1	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
5	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	The	Der	6	6	2	1	3	5	5	2	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
6	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	active_substance	Wirkstoff	7	7+8	2	2	15	6	6	2	1	16	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
7	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	in	in	9	9	2	1	2	7	7	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
8	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	10	10	2	1	8	8	8	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
9	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	11	11	2	1	1	9	9	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
10	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	topotecan	Topotecan	12	12	2	1	9	10	10	2	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
11	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	13	13	2	1	1	11	11	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
12	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	is	ist	14	14	2	1	2	12	12	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
13	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	an	ein	15	15	2	1	2	13	13	2	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
14	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	anticancer	gegen_Krebs	16	16	2	1	10	15	15+16	2	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
15	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	medicine	Arzneimittel	17	17	2	1	8	14	14	2	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
16	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	that	,_das	18	18	2	1	4	17	17+18	2	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
17	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	belongs	gehört	19	19	2	1	7	27	27	2	1	7	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	6865	17940	193988	[gehört	6865	176048	6	0	1014	177062	gehört[	0	0	0	0	0	0	---	0	0	0	0	0	---	[gehört
18	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	to_the	zur	20	20+21	2	2	5	19	19	2	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-8	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
19	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	group	Gruppe	22	22	2	1	5	20	20	2	1	5	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	80668	6865	176048	[gehört_	80668	169183	0	1	0	169183	gehört_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[gehört_
20	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	""""	""""	23	23	2	1	1	22	22	2	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
21	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	topoisomerase	Topoisomerase_-	24	24	2	1	13	23	23+24	2	2	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
22	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	inhibitors	Hemmer	25	25	2	1	10	25	25	2	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
23	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	an	---	26	89	2	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	64	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
24	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	It	Es	28	28	3	1	2	29	29	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	-61	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
25	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	blocks	blockiert	29	29	3	1	6	30	30	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
26	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	an	das	30	30	3	1	2	31	31	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
27	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	enzyme	Enzym	31	31	3	1	6	32	32	3	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
28	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	topoisomerase	Topoisomerase	33	33	3	1	13	33	33	3	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
29	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	I	I	34	34	3	1	1	34	34	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
30	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	35	35	3	1	1	35	35	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
31	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	which	das	36	36	3	1	5	36	36	3	1	5	8	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	858	671	268463	[das_	858	267792	4	0	530	268322	das_	0	0	0	0	0	0	---	0	0	0	0	0	---	[das_
32	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	is	ist	37	37	3	1	2	43	43	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
33	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	involved	beteiligt	38	38	3	1	8	42	42	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
34	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	in	an	39	39	3	1	2	37	37	3	1	2	4	12	2	-2.4286	0	0	0	0	0	0	0	0	0	0	0	0	-5	1	70701	90418	356931	die_inan	70560	265842	0	6	1092	266934	die_in]	141	268463	2	0	140	268603	an[	0	0	0	0	0	---	die_inan
35	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	der	40	40	3	1	3	38	38	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
36	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	division	Teilung	41	41	3	1	8	39	39	3	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
37	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	of	der	42	42	3	1	2	40	40	3	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
38	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	DNA	DNA	43	43	3	1	3	41	41	3	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
39	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	44	44	3	1	1	44	44	3	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
40	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	an	---	27	89	3	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	45	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
41	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	an	---	32	89	3	1	2	0	0	0	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
42	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	When	Wenn	45	45	4	1	4	45	45	4	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	-44	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
43	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	das	46	46	4	1	3	46	46	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
44	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	enzyme	Enzym	47	47	4	1	6	47	47	4	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
45	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	is	ist	48	48	4	1	2	49	49	4	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
46	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	blocked	blockiert	49	49	4	1	7	48	48	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
47	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	50	50	4	1	1	50	50	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
48	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	die	51	51	4	1	3	52	52	4	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
49	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	DNA	DNA_-	52	52	4	1	3	53	53+54	4	2	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
50	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	strands	Stränge	53	53	4	1	7	55	55	4	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
51	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	break	brechen	54	54	4	1	5	51	51	4	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
52	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	55	55	4	1	1	56	56	4	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
53	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	This	Dies	56	56	5	1	4	57	57	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
54	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	prevents	verhindert_,	57	57	5	1	8	58	58+59	5	2	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
55	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	die	58	58	5	1	3	61	61	5	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
56	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	cancer_cells	Krebszellen	59	59+60	5	2	11	62	62	5	1	12	0	28	1	-1.0741	0	0	0	0	0	0	0	0	0	0	0	0	1	2	88328	1965	358896	[gnulieT_red_na	88328	356931	0	14	1248	358179	gnulieT_red_na]	0	0	0	0	0	0	---	0	0	0	0	0	---	[gnulieT_red_na
57	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	from	dass	61	61	5	1	4	60	60	5	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
58	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	dividing	sich_teilen	62	62	5	1	8	63	63+64	5	2	7	22	2	1	1.1905	0	0	0	0	0	0	0	0	0	0	0	0	4	1	717	46067	404963	[sich_teilen[,	717	358896	11	1	2590	361486	sich_teilen[,]	0	0	0	0	0	0	---	0	0	0	0	0	---	[sich_teilen[,
59	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	and	und	63	63	5	1	3	65	65	5	1	3	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	9813	49374	464353	[sie_	9813	414979	0	1	0	414979	sie_	0	0	0	0	0	0	---	0	0	0	0	0	---	[sie_
60	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	they	sie	64	64	5	1	4	70	70	5	1	4	8	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	97314	1372	1060058	sie_	0	0	0	0	0	0	---	0	0	0	0	0	0	---	97314	1058686	4	0	1372	sie_	sie_
61	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	eventually	schließlich	65	65	5	1	10	71	71	5	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
62	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	die	absterben	66	66	5	1	3	72	72	5	1	3	4	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	43477	10016	414979	[ab	43477	404963	2	0	203	405166	ab[	0	0	0	0	0	0	---	0	0	0	0	0	---	[ab
63	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	67	67	5	1	1	73	73	5	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
64	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	68	68	6	1	8	74	74	6	1	8	0	20	1	-1.1053	0	0	0	0	0	0	0	0	0	0	0	0	1	1	49374	2449	466802	hcis_tkriw	49374	464353	0	10	1607	465960	hcis_tkriw]	0	0	0	0	0	0	---	0	0	0	0	0	---	hcis_tkriw
65	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	also	auch	69	69	6	1	4	76	76	6	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
66	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	affects	hat_Auswirkungen_auf	70	70	6	1	7	75	75+77+78	6	3	5	32	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	842	9765	476567	[hatAuswirkungen_	842	466802	16	0	5523	472325	hatAuswirkungen_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[hatAuswirkungen_
67	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	non	Nicht	71	71	6	1	3	79	79	6	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
68	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	-	-	72	72	6	1	1	80	80	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
69	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	cancer_cells	Krebszellen	73	73+74	6	2	11	81	81	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
70	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	75	75	6	1	1	82	82	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
71	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	which	was	76	76	6	1	5	83	83	6	1	5	8	2	1	1.5714	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4242	15257	491824	[die_]was_	4242	476567	4	1	937	477504	die_]was_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[die_]was_
72	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	causes	verursacht	77	77	6	1	6	85	85	6	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
73	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	side_effects	Nebenwirkungen	78	78+79	6	2	11	84	84	6	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
74	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	80	80	6	1	1	86	86	6	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
75	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	How	Wie	81	81	7	1	3	87	87	7	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
76	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	has_been	wurde	82	82+84	7	2	7	88	88	7	1	8	12	2	2	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	3	35193	199355	730522	[hat_]wurde[_	14320	491824	5	1	703	492527	hat_]wurde	20873	678121	1	0	0	678121	_	0	0	0	0	0	---	[hat_]wurde[_
77	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	83	83	7	1	8	92	92	7	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	-1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
78	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	studied	untersucht	85	85	7	1	7	94	94	7	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
79	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	?	?	86	86	7	1	1	95	95	7	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
80	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	87	87	8	1	8	99	99	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
81	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	as	als	88	88	8	1	2	100	100	8	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
82	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	infusion	Infusion	90	90	8	1	8	101	101	8	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
83	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	has	ist	91	91	8	1	3	102	102	8	1	3	8	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	146251	764	639542	ist_	146251	638778	4	0	546	639324	ist_	0	0	0	0	0	0	---	0	0	0	0	0	---	ist_
84	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	been	worden	92	92	8	1	4	111	111	8	1	4	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	9	1	140	7644	655532	worden	140	647888	6	0	780	648668	worden[	0	0	0	0	0	0	---	0	0	0	0	0	---	worden
85	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	studied	untersucht	93	93	8	1	7	110	110	8	1	7	22	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	3915	1607	647888	[untersucht_	3915	646281	11	0	1467	647748	untersucht_	0	0	0	0	0	0	---	0	0	0	0	0	---	[untersucht_
86	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	in	bei	94	94	8	1	2	103	103	8	1	2	8	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-7	1	218	1669	641211	bei_	218	639542	4	0	624	640166	bei_[	0	0	0	0	0	0	---	0	0	0	0	0	---	bei_
87	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	more	mehr	95	95	8	1	4	104	104	8	1	4	0	14	1	-1.1538	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1045	5070	646281	[hat_in_	1045	641211	0	7	1155	642366	hat_in_]	0	0	0	0	0	0	---	0	0	0	0	0	---	[hat_in_
88	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	than	als	96	96	8	1	4	105	105	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
89	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	480	480	97	97	8	1	3	106	106	8	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
90	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	women	Frauen	98	98	8	1	5	107	107	8	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
91	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	with	mit	99	99	8	1	4	108	108	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
92	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	ovarian_cancer	Eierstockkrebs	100	100+101	8	2	13	109	109	8	1	14	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
93	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	who	,_bei_denen	102	102	8	1	3	112	112+113+114	8	3	1	20	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	52401	5694	736216	bei_denen_	52401	730522	10	0	4586	735108	bei_denen_[	0	0	0	0	0	0	---	0	0	0	0	0	---	bei_denen_
94	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	had	war	103	103	8	1	3	124	124	8	1	3	0	6	1	-1.4000	0	0	0	0	0	0	0	0	0	0	0	0	10	1	6864	22589	678121	[wordenuntersucht__	6864	655532	0	3	1716	657248	wordenuntersucht__]	0	0	0	0	0	0	---	0	0	0	0	0	---	[wordenuntersucht__
95	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	failed	gescheitert	104	104	8	1	6	123	123	8	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
96	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	one	eine	105	105	8	1	3	115	115	8	1	3	0	8	1	-1.2857	0	0	0	0	0	0	0	0	0	0	0	0	-8	1	1108	7894	744110	[die_	1108	736216	0	4	577	736793	die_	0	0	0	0	0	0	---	0	0	0	0	0	---	[die_
97	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	treatment	Behandlungen	106	106	8	1	9	117	117	8	1	9	4	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	31262	8579	783951	[en	31262	775372	2	0	187	775559	en[	0	0	0	0	0	0	---	0	0	0	0	0	---	[en
98	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	with	mit	107	107	8	1	4	118	118	8	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
99	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	platinum_-_containing	platinhaltigen	108	108+109+110	8	3	19	119	119	8	1	21	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	3	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
100	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	anticancer	gegen_Krebs	111	111	8	1	10	121	121+122	8	2	9	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	7317	31262	775372	,	7317	744110	0	1	0	744110	,]	0	0	0	0	0	0	---	0	0	0	0	0	---	,
101	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	medicines	Arzneimitteln	112	112	8	1	9	120	120	8	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
102	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	113	113	8	1	1	125	125	8	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
103	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Three	Drei	114	114	9	1	5	126	126	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
104	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	studies	Studien	115	115	9	1	7	127	127	9	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
105	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	were	waren	116	116	9	1	4	128	128	9	1	4	12	2	1	1.3636	0	0	0	0	0	0	0	0	0	0	0	0	1	1	8392	18862	802813	[seien_]waren_	8392	783951	6	1	2981	786932	seien_]waren_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[seien_]waren_
106	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	""""	""""	117	117	9	1	1	129	129	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
107	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	open	offen	118	118	9	1	4	130	130	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
108	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	119	119	9	1	1	132	132	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
109	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	""""	""""	120	120	9	1	1	131	131	9	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
110	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	meaning	was_bedeutet	121	121	9	1	7	133	133+134	9	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
111	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	that	,_dass	122	122	9	1	4	135	135+136	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
112	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	das	123	123	9	1	3	137	137	9	1	3	6	8	1	-15.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	15881	1794	804607	[Medizin__ei]as_	15881	802813	3	4	1591	804404	Medizin__ei]as_	0	0	0	0	0	0	---	0	0	0	0	0	---	[Medizin__ei]as_
113	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	medicine	Arzneimittel	124	124	9	1	8	138	138	9	1	8	26	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	203	14289	818896	Arzneimittel_	203	804607	13	0	2636	807243	Arzneimittel_	0	0	0	0	0	0	---	0	0	0	0	0	---	Arzneimittel_
114	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	was	wurde	125	125	9	1	3	145	145	9	1	3	12	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	7	1	11653	20577	839473	wurde_	11653	818896	6	0	983	819879	wurde_[	0	0	0	0	0	0	---	0	0	0	0	0	---	wurde_
115	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	not	nicht	126	126	9	1	3	139	139	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-6	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
116	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	compared	verglichen	127	127	9	1	8	144	144	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	5	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
117	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	to	mit	128	128	9	1	2	140	140	9	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-4	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
118	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	any	einer	129	129	9	1	3	141	141	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
119	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	other	anderen	130	130	9	1	5	142	142	9	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
120	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	treatment	Behandlung	131	131	9	1	9	143	143	9	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
121	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	and	und	132	132	9	1	3	146	146	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
122	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	die	133	133	9	1	3	147	147	9	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
123	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	patients	Patienten	134	134	9	1	8	148	148	9	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
124	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	knew	wussten	135	135	9	1	4	149	149	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
125	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	that	,_dass	136	136	9	1	4	150	150+151	9	2	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
126	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	they	sie	137	137	9	1	4	152	152	9	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
127	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	were_receiving	erhielten	138	138+139	9	2	13	154	154	9	1	14	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	2	1965	45771	890423	[_	1965	844652	0	1	0	844652	_	0	0	0	0	0	0	---	0	0	0	0	0	---	[_
128	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	140	140	9	1	8	153	153	9	1	8	4	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-1	1	2668	2511	844652	[Hycamtin_	2668	842141	2	0	546	842687	Hycamtin_[	0	0	0	0	0	0	---	0	0	0	0	0	---	[Hycamtin_
129	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	141	141	9	1	1	155	155	9	1	1	0	2	1	-3.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	19594	2668	842141	[Hycamtin	19594	839473	0	1	0	839473	Hycamtin]	0	0	0	0	0	0	---	0	0	0	0	0	---	[Hycamtin
130	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	The	Die	142	142	10	1	3	156	156	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
131	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	fourth	vierte	143	143	10	1	6	157	157	10	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
132	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	study	Studie	144	144	10	1	5	158	158	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
133	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	involved	umfasste	145	145	10	1	8	159	159	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
134	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	226	226	146	146	10	1	3	160	160	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
135	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	women	Frauen	147	147	10	1	5	161	161	10	1	5	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
136	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	,	,	148	148	10	1	1	162	162	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
137	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	and	und	149	149	10	1	3	163	163	10	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
138	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	compared	verglich	150	150	10	1	8	164	164	10	1	8	0	4	1	-1.6667	0	0	0	0	0	0	0	0	0	0	0	0	1	1	45771	69810	960233	ne	45771	890423	0	2	1232	891655	ne]	0	0	0	0	0	0	---	0	0	0	0	0	---	ne
139	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	Hycamtin	Hycamtin	151	151	10	1	8	165	165	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
140	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	with	mit	152	152	10	1	4	166	166	10	1	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
141	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	paclitaxel	Paclitaxel	153	153	10	1	10	167	167	10	1	10	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
142	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	(	(	154	154	10	1	1	168	168	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
143	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	another	ein_anderes	155	155	10	1	7	169	169+170	10	2	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
144	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	anticancer	gegen_Krebs	156	156	10	1	10	172	172+173	10	2	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
145	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	medicine	Arzneimittel	157	157	10	1	8	171	171	10	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
146	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	)	)	158	158	10	1	1	174	174	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
147	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	159	159	10	1	1	175	175	10	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
148	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	The	Der	160	160	11	1	3	176	176	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
149	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	main_measure	Hauptindikator	161	161+162	11	2	11	177	177	11	1	12	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
150	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	of	für	163	163	11	1	2	178	178	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
151	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	effectiveness	Wirksamkeit	164	164	11	1	13	180	180	11	1	13	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
152	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	was	war	165	165	11	1	3	181	181	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
153	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	the	die	166	166	11	1	3	182	182	11	1	3	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
154	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	number	Anzahl	167	167	11	1	6	183	183	11	1	6	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
155	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	of	der	168	168	11	1	2	184	184	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
156	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	patients	Patienten	169	169	11	1	8	185	185	11	1	8	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
157	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	whose	,_deren	170	170	11	1	5	186	186+187	11	2	4	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
158	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	tumours	Tumoren	171	171	11	1	7	188	188	11	1	7	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
159	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	responded	ansprachen	172	172	11	1	9	192	192	11	1	9	16	0	1	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	4	1	68578	98453	1058686	[sprachen	68578	960233	8	0	1139	961372	sprachen	0	0	0	0	0	0	---	0	0	0	0	0	---	[sprachen
160	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	to	auf	173	173	11	1	2	189	189	11	1	2	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	-3	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
161	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	treatment	Behandlung	174	174	11	1	9	191	191	11	1	9	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---
162	OCT13	P28_PF03	OCT13@P28_PF03	en	de	PF	03	P28	.	.	175	175	11	1	1	193	193	11	1	1	0	0	0	1.0000	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	0	---	0	0	0	0	0	---	---